FDA Data MCP

Agent readability score

Strengths

• Tool names are specific and actionable (e.g., 'fda_lookup_company')
• Descriptions clarify use cases and data scope (e.g., 'excludes inspection history')
• Costs and limitations are explicitly documented for most tools

Weaknesses

• Some parameters lack required/optional clarity (e.g., 'operations' filter in 'fda_search_facilities')
• Ambiguous error handling for tools like 'fda_search_aphis' (no cost/constraint mention)
• Overlapping recall-related tools ('fda_search_enforcement' vs 'fda_search_recall_text') may confuse agents

• fda_search_aphis — No cost/constraint documentation
• fda_search_510k — Could use more descriptive name
• fda_search_enforcement — Overlaps with 'fda_search_recall_text' in recall scope

Verdict

The FDA Data MCP offers robust, well-documented tools with clear naming and use cases. However, some parameters lack required/optional definitions, and overlapping recall tools may create ambiguity. Overall, the 85/100 score reflects strong tool coverage with minor refinement opportunities.

9/6/2026, 9:05:05 PM

Event narrative